Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4000302A · kind A · utility
10Cited by
3References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1975 |
| Grant date | Dec 28, 1976 |
| Priority date | — |
| Expiry date | Apr 16, 1995 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors by administering an antihistamine and an H-2 histamine receptor inhibitor. Exemplary of the antihistamine in the compositions and methods of this invention is mepyramine and exemplary of the H-2 histamine receptor inhibitor is N-cyano-N'-methyl-N"-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidin e.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.